Geismar, Cyril

Spike-antibody waning after second dose of BNT162b2 or ChAdOx1

Shrotri, M., Navaratnam, A. M. D., Nguyen, V., Byrne, T., Geismar, C., Fragaszy, E., Beale, S., Fong, W. L. E., Patel, P., Kovar, J., et al. (2021) · The Lancet

SARS-CoV-2 and COVID-19 ResearchImmune responses and vaccinations

Cited by 393

Ebola virus disease mathematical models and epidemiological parameters: a systematic review

Nash, R. K., Bhatia, S., Morgenstern, C., Doohan, P., Jorgensen, D., McCain, K., McCabe, R., Nikitin, D., Forna, A., Cuomo-Dannenburg, G., et al. (2024) · The Lancet Infectious Diseases

Viral Infections and Outbreaks ResearchMathematical and Theoretical Epidemiology and Ecology Models

Cited by 35

Severe acute respiratory syndrome (SARS) mathematical models and disease parameters: a systematic review

Morgenstern, C., Rawson, T., Routledge, I., Kont, M., Imai-Eaton, N., Skarp, J., Doohan, P., McCain, K., Johnson, R., Unwin, H. J. T., et al. (2025) · The Lancet Microbe

COVID-19 epidemiological studiesSARS-CoV-2 and COVID-19 Research

Cited by 6